Redefine What’s Possible: A Potential New Treatment Paradigm for Patients with Ischemic Disorders
DiaMedica Therapeutics is committed to improving the lives of individuals battling serious vascular diseases by developing innovative therapies that reduce ischemia. With an initial focus on preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS), we are dedicated to advancing patient care through a novel approach that centers around reversing the effects of the ischemic injury to improve patient outcomes.
Our Focus